These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 29189166)

  • 1. Oxytocin and Eating Disorders: A Narrative Review on Emerging Findings and Perspectives.
    Giel K; Zipfel S; Hallschmid M
    Curr Neuropharmacol; 2018; 16(8):1111-1121. PubMed ID: 29189166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current findings on the role of oxytocin in the regulation of food intake.
    Spetter MS; Hallschmid M
    Physiol Behav; 2017 Jul; 176():31-39. PubMed ID: 28284882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Neuropeptide Hormone Oxytocin in Eating Disorders.
    Plessow F; Eddy KT; Lawson EA
    Curr Psychiatry Rep; 2018 Sep; 20(10):91. PubMed ID: 30178087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurohypophyseal hormone oxytocin and eating behaviors: a narrative review.
    Iovino M; Messana T; Marucci S; Triggiani D; Giagulli VA; Guastamacchia E; Piazzolla G; De Pergola G; Lisco G; Triggiani V
    Hormones (Athens); 2024 Mar; 23(1):15-23. PubMed ID: 37979096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of oxytocin on eating behaviours and stress in women with bulimia nervosa and binge eating disorder.
    Leslie M; Leppanen J; Paloyelis Y; Treasure J
    Mol Cell Endocrinol; 2019 Nov; 497():110354. PubMed ID: 30579958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study investigating the influence of oxytocin on attentional bias to food images in women with bulimia nervosa or binge eating disorder.
    Leslie M; Leppanen J; Paloyelis Y; Treasure J
    J Neuroendocrinol; 2020 May; 32(5):e12843. PubMed ID: 32202692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin and eating disorders: Knowledge gaps and future directions.
    Russell J; Hunt GE
    Psychoneuroendocrinology; 2023 Aug; 154():106290. PubMed ID: 37178641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II randomised controlled trial of intranasal oxytocin in anorexia nervosa.
    Maguire S; Kesby A; Brownlow R; Hunt GE; Kim M; McAulay C; Grisham JR; McGregor IS; Suraev A; Kevin RC; Russell J
    Psychoneuroendocrinology; 2024 Jun; 164():107032. PubMed ID: 38520886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Oxytocin on Food Intake and Emotion Recognition in Patients with Eating Disorders: A Double Blind Single Dose Within-Subject Cross-Over Design.
    Kim YR; Eom JS; Yang JW; Kang J; Treasure J
    PLoS One; 2015; 10(9):e0137514. PubMed ID: 26402337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of intranasal oxytocin in the treatment of eating disorders.
    Malewska-Kasprzak M; Jowik K; Tyszkiewicz-Nwafor M
    Neuropeptides; 2023 Dec; 102():102387. PubMed ID: 37837804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin's inhibitory effect on food intake is stronger in obese than normal-weight men.
    Thienel M; Fritsche A; Heinrichs M; Peter A; Ewers M; Lehnert H; Born J; Hallschmid M
    Int J Obes (Lond); 2016 Nov; 40(11):1707-1714. PubMed ID: 27553712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrinology and brain imaging of reward in eating disorders: A possible key to the treatment of anorexia nervosa and bulimia nervosa.
    Monteleone AM; Castellini G; Volpe U; Ricca V; Lelli L; Monteleone P; Maj M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):132-142. PubMed ID: 28259721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial.
    Palavras MA; Hay P; Touyz S; Sainsbury A; da Luz F; Swinbourne J; Estella NM; Claudino A
    Trials; 2015 Dec; 16():578. PubMed ID: 26683478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of oxytocin on risk-taking in the balloon analogue risk task among women with bulimia nervosa and binge eating disorder.
    Leslie M; Leppanen J; Paloyelis Y; Nazar BP; Treasure J
    J Neuroendocrinol; 2019 Aug; 31(8):e12771. PubMed ID: 31283053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin reduces reward-driven food intake in humans.
    Ott V; Finlayson G; Lehnert H; Heitmann B; Heinrichs M; Born J; Hallschmid M
    Diabetes; 2013 Oct; 62(10):3418-25. PubMed ID: 23835346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations.
    Demitrack MA; Lesem MD; Listwak SJ; Brandt HA; Jimerson DC; Gold PW
    Am J Psychiatry; 1990 Jul; 147(7):882-6. PubMed ID: 2356873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin and Food Intake Control: Neural, Behavioral, and Signaling Mechanisms.
    Liu CM; Spaulding MO; Rea JJ; Noble EE; Kanoski SE
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal oxytocin reduces weight gain in diet-induced obese prairie voles.
    Seelke AM; Rhine MA; Khun K; Shweyk AN; Scott AM; Bond JM; Graham JL; Havel PJ; Wolden-Hanson T; Bales KL; Blevins JE
    Physiol Behav; 2018 Nov; 196():67-77. PubMed ID: 30144467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacologic Management of Eating Disorders.
    Muratore AF; Attia E
    Curr Psychiatry Rep; 2022 Jul; 24(7):345-351. PubMed ID: 35576089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intranasal oxytocin in food intake and craving: A meta-analysis of clinical trials.
    Chen CY; Chiang YC; Kuo TC; Tam KW; Loh EW
    Clin Nutr; 2021 Oct; 40(10):5407-5416. PubMed ID: 34600216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.